GetTopicDetailResponse(id=7ba64580946, topicName=安慰劑反應(yīng), introduction=安慰劑反應(yīng), content=null, image=null, comments=3, allHits=1182, url=https://h5.medsci.cn/topic?id=45809, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=102883, tagList=[TagDto(tagId=102883, tagName=安慰劑反應(yīng))], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1928255, encodeId=4856192825509, content=<a href='/topic/show?id=7ba64580946' target=_blank style='color:#2F92EE;'>#安慰劑反應(yīng)#</a>, objectTitle=J Rheumatol：類風(fēng)濕性關(guān)節(jié)炎臨床試驗中的安慰劑反應(yīng), objectType=article, longId=186267, objectId=a8e218626e3f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8e218626e3f, replyNumber=0, likeNumber=0, createdTime=2020-07-02, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8e218626e3f, moduleTitle=J Rheumatol：類風(fēng)濕性關(guān)節(jié)炎臨床試驗中的安慰劑反應(yīng), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a8e218626e3f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1928256, encodeId=275e192825691, content=<a href='/topic/show?id=7ba64580946' target=_blank style='color:#2F92EE;'>#安慰劑反應(yīng)#</a>, objectTitle=JAMA Netw Open：參加磷酸二酯酶5抑制劑試驗的男性勃起功能障礙患者的安慰劑反應(yīng), objectType=article, longId=192982, objectId=9a0219298208, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a0219298208, replyNumber=0, likeNumber=104, createdTime=2020-06-30, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a0219298208, moduleTitle=JAMA Netw Open：參加磷酸二酯酶5抑制劑試驗的男性勃起功能障礙患者的安慰劑反應(yīng), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9a0219298208)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1928254, encodeId=ca5819282549a, content=<a href='/topic/show?id=7ba64580946' target=_blank style='color:#2F92EE;'>#安慰劑反應(yīng)#</a>, objectTitle=Lancet子刊：25年來抗抑郁藥試驗中的安慰劑反應(yīng)率趨勢, objectType=article, longId=79622, objectId=bff9e9622c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bff9e9622c9, replyNumber=0, likeNumber=67, createdTime=2017-03-15, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bff9e9622c9, moduleTitle=Lancet子刊：25年來抗抑郁藥試驗中的安慰劑反應(yīng)率趨勢, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bff9e9622c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
